.png)
CuriRx, Inc., established in 2012, is dedicated to setting new standards of care in critical therapeutic areas with unmet medical needs. Our mission involves collaborating closely with our clients to offer innovative development solutions encompassing pharmaceutics, biopharmaceutics, vaccines, generics, and biosimilars. Our distinctive approach emphasizes:
Strong Collaboration: We foster robust partnerships with clients.
Customized Development Plans: Tailored strategies for individual needs.
Open Consultation: We engage in open discussions with a wealth of consultative expertise.
Iterative Ideation: Continual refinement to achieve optimal results.
Maximized Efficacy: Prioritizing effectiveness in all endeavors.
Guaranteed Commitment and Satisfaction: We assure dedicated commitment and customer contentment.
As a contract services company, we specialize in research and development for the biotech and pharmaceutical sectors. Our seasoned scientists possess over 30 years of experience in formulation development, encompassing diverse areas such as small molecules, peptides, proteins, vaccines, biosimilars, oligonucleotides, bacteria, cells, dextrans, combination products, conjugated products, antibodies, bispecific antibodies, and more.
Our comprehensive services span formulation development, lyophilization, cell culture, purification, analytical development, and more. We possess the capability to produce non-GMP vials for animal studies and provide non-GMP stability support studies. Noteworthy achievements include successful development projects like HUMIRA® and Synagis®.
Beyond R&D services, we extend our expertise to consultation in operational management, project management, GMP, cGMP, customized aseptic technique training, product development, and various other domains. At CuriRx, we are committed to advancing healthcare through innovation and collaboration.